Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years

ConclusionsSerological ABO HDFN is a relatively frequent event when an O‐A/O‐B incompatibility between mothers and their newborn occurs and, in most cases, translates into a self‐limiting disease, with a small number of newborns requiring invasive treatments. The DAT test, although not predictive of disease severity, appears to be a useful tool to monitor babies born from O‐A/O‐B‐incompatible pregnancies and to identify those who may require treatment.

Source: Transfusion Medicine - January 25, 2018 Category: Hematology Authors: A. Matteocci, A. De Rosa, E. Buffone, L. Pierelli Tags: SHORT COMMUNICATION Source Type: research